Taku Okazaki
Impact in
- Immunology top 0.05%
- Immune Cell Function and Interaction
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Immune cells in cancer
- Oncology top 0.05%
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
Papers in
- Immunology 48
- Immune Cell Function and Interaction 40
- T-cell and B-cell Immunology 22
- Immunotherapy and Immune Responses 17
- Oncology 39
- Cancer Immunotherapy and Biomarkers 35
- CAR-T cell therapy research 13
- Co-authors
- Tasuku Honjo (30 shared papers)Yoshiko Iwai (8 shared papers)Yoshimasa Tanaka (10 shared papers)Nagahiro Minato (9 shared papers)Hiroyuki Nishimura (5 shared papers)T Honjo (2 shared papers)Masayoshi Ishida (3 shared papers)Hiroshi Hiai (5 shared papers)
- Journals
- Proceedings of the National Academy of Sciences (10 papers)International Immunology (6 papers)The Journal of Experimental Medicine (4 papers)Nature Immunology (4 papers)The Journal of Immunology (3 papers)
- Partner nations
- JapanUnited StatesSwitzerland
In The Last Decade
Taku Okazaki
70 papers receiving 19.7k citations
Taku Okazaki's Hit Papers
Peers
Comparison fields: 5 of 125
- Immunology 11.9k
- Oncology 12.4k
- Endocrine and Autonomic Systems 872
- Hepatology 524
- Pulmonary and Respiratory Medicine 1.8k
Countries citing papers authored by Taku Okazaki
This map shows the geographic impact of Taku Okazaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Taku Okazaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Taku Okazaki more than expected).
Fields of papers citing papers by Taku Okazaki
This network shows the impact of papers produced by Taku Okazaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Taku Okazaki. The network helps show where Taku Okazaki may publish in the future.
Co-authors
The 25 scholars most cited alongside Taku Okazaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 70 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte Activation Hit paper breakdown → | 2000 | 4158 |
| 2 | Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade Hit paper breakdown → | 2002 | 2441 |
| 3 | Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice Hit paper breakdown → | 2001 | 1467 |
| 4 | Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer Hit paper breakdown → | 2007 | 1155 |
| 5 | PD-1 and PD-1 ligands: from discovery to clinical application Hit paper breakdown → | 2007 | 1014 |
| 6 | A rheostat for immune responses: the unique properties of PD-1 and their advantages for clinical application Hit paper breakdown → | 2013 | 713 |
| 7 | PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine Hit paper breakdown → | 2001 | 676 |
| 8 | The PD-1–PD-L pathway in immunological tolerance Hit paper breakdown → | 2006 | 581 |
| 9 | Autoantibodies against cardiac troponin I are responsible for dilated cardiomyopathy in PD-1-deficient mice Hit paper breakdown → | 2003 | 544 |
| 10 | Tumor cell expression of programmed cell death‐1 ligand 1 is a prognostic factor for malignant melanoma Hit paper breakdown → | 2010 | 537 |
| 11 | Resting dendritic cells induce peripheral CD8+ T cell tolerance through PD-1 and CTLA-4 Hit paper breakdown → | 2005 | 432 |
| 12 | 1995 | 387 | |
| 13 | Establishment of NOD-Pdcd1-/-mice as an efficient animal model of type I diabetes Hit paper breakdown → | 2005 | 365 |
| 14 | The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors Hit paper breakdown → | 2008 | 353 |
| 15 | 2020 | 316 | |
| 16 | 2003 | 308 | |
| 17 | 2019 | 285 | |
| 18 | IFN-α Directly Promotes Programmed Cell Death-1 Transcription and Limits the Duration of T Cell-Mediated Immunity Hit paper breakdown → | 2011 | 278 |
| 19 | 2010 | 261 | |
| 20 | PD-1 and LAG-3 inhibitory co-receptors act synergistically to prevent autoimmunity in mice Hit paper breakdown → | 2011 | 255 |
About Taku Okazaki
Taku Okazaki is a scholar working on Immunology, Oncology, Genetics, Molecular Biology and Physiology, having authored 70 papers that have together received 20.0k indexed citations. Recurring topics across this work include Immune Cell Function and Interaction (40 papers), Cancer Immunotherapy and Biomarkers (35 papers), T-cell and B-cell Immunology (22 papers), Immunotherapy and Immune Responses (17 papers), CAR-T cell therapy research (13 papers), Diabetes and associated disorders (7 papers), Adipose Tissue and Metabolism (4 papers) and Liver Diseases and Immunity (4 papers). The work is most often cited by research in Immunology (11.9k citations), Oncology (12.4k citations), Endocrine and Autonomic Systems (872 citations), Hepatology (524 citations) and Pulmonary and Respiratory Medicine (1.8k citations). Taku Okazaki has collaborated with scholars based in Japan, United States and Switzerland. Frequent co-authors include Tasuku Honjo, Yoshiko Iwai, Yoshimasa Tanaka, Nagahiro Minato, Hiroyuki Nishimura, T Honjo, Masayoshi Ishida, Hiroshi Hiai, Il‐mi Okazaki and Daisuke Sugiura. Their work appears in journals such as Proceedings of the National Academy of Sciences, International Immunology, The Journal of Experimental Medicine, Nature Immunology and The Journal of Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.